Skip to main content
Log in

Left ventricular hypertrophy as a marker of adverse cardiovascular risk in persons of different age groups

  • Published:
Advances in Gerontology Aims and scope Submit manuscript

Abstract

The paper considers modern views on the prognostic value of different types of left ventricular hypertrophy (LVH). The role of the interaction of demographic, hemodynamic, regulatory, and intracardiac factors in the formation of prognostic traits in patients with different types of LVH is noted. Data are presented from our own studies, which indicate that the left ventricular myocardial mass is no less important in long-term general prognostication than concentric or eccentric LVH type classification in elderly patients with hypertension. Some data are submitted concerning left atrial dilatation as an inalienable component of the cardiovascular continuum in essential hypertension. The pathogenic and prognostic contribution of metabolic disorders associated with hypertension and abdominal obesity in the development of structural and functional disorders on the heart’s left side is shown. Issues of long-term outcome in elderly hypertensive patients with metabolic syndrome are highlighted, and characteristics of left ventricular geometry are taken into account.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Artyunov, G.P., Problems of arterial hypertension, Consilium Med., 2001, special issue, pp. 5–7.

    Google Scholar 

  2. Barsukov, A.V. and Glukhovskoy, D.V., Specific lipid metabolism and cardiovascular medical history of patients with arterial hypertension depending on volume of left auricle, in Mater. Vseros. nauchno-prakt. konf. s mezhd. uchestiem “Stoletie infil’tratsionnoi teorii ateroskleroza akademika N.N. Anichkova” (Proc. AllRuss. Sci.-Pract. Conf. with Int. Participation “The 100th Anniversary of the Anichkov’s Infiltration Theory of Atherosclerosis”), St. Petersburg, 2013, pp. 17–18.

    Google Scholar 

  3. Barsukov, A.V. and Zobnina, M.P., General forecast for patients with arterial hypertension depending on degree of left ventricular hypertrophy and lipid metabolism parameters, in Mater. Vseros. nauchno-prakt. konf. s mezhd. uchestiem “Stoletie infil’tratsionnoi teorii ateroskleroza akademika N.N. Anichkova” (Proc. AllRuss. Sci.-Pract. Conf. with Int. Participation “The 100th Anniversary of the Anichkov’s Infiltration Theory of Atherosclerosis”), St. Petersburg, 2013, p. 18.

    Google Scholar 

  4. Barsukov, A.V., Zobnina, M.P., and Talantseva, T.S., Left ventricular hypertrophy and forecast: the data of the five-year retrospective observation of patients with essential hypertension, Arterial’naya Gipertenz., 2012, vol. 18, no. 5, pp. 385–397.

    Google Scholar 

  5. Barsukov, A.V., Pronina, E.V., and Shustov, S.B., Pathogenesis and cure of asymmetric left ventricular hypertrophy at essential hypertension, Arterial’naya Gipertenz., 2008, vol. 14, no. 4, pp. 360–369.

    Google Scholar 

  6. Barsukov, A.V., Glukhovskoy, D.V., Babanova, A.Ya., and Zobnina, M.P., Remodeling of left auricle of patients with arterial hypertension depending on carbohydrate metabolism, in Sbornik nauchnykh rabot 442-go Okruzhnogo Voennogo Klinicheskogo Gospitalya, Ministerstva Oborony Rossii (Bulletin of Research Works of the Regional Military Clinical Hospital no. 442, Ministry of Defense of Russian Federation), St. Petersburg, 2011, p. 289.

    Google Scholar 

  7. Barsukov, A.V., Sveklina, T.S., Suyundikova, M.G., et al., Subclinical lesions of target organs in patients with arterial hypertension, pancreatic diabetes, and atrial fibrillation, in Mater. Vseros. nauchno-prakt. konf. “Aktual’nye voprosy vnutrennei meditsiny” (Proc. AllRuss. Sci.-Pract. Conf. “Relevant Problems of Inner Medicine”), St. Petersburg, 2010, pp. 25–29.

    Google Scholar 

  8. Glukhovskoy, D.V., Complex assessment of clinicallaboratory-instrumental parameters of patients with arterial hypertension depending on specific remodeling of left auricle, Extended Abstract of Cand. Sci. (Med.) Dissertation, St. Petersburg, 2013.

    Google Scholar 

  9. Zobnina, M.P., Retrospective analysis of survival rate of patients with essential arterial hypertension depending on initial parameters of remodeling of left auricle, Extended Abstract of Cand. Sci. (Med.) Dissertation, St. Petersburg, 2013.

    Google Scholar 

  10. Koziolova, N.A., Shatunova, O.A., and Lazarev, Ia., Risk factors of development of left ventricular hypertrophy in patients with hypertension with strong tendency to treatment, Kardiologiya, 2012, vol. 52, no. 4, pp. 25–30.

    CAS  PubMed  Google Scholar 

  11. Konradi, A.O., Treatment of arterial hypertension in specific groups of patients: left ventricular hypertrophy, Arterial’naya Gipertenz., 2005, vol. 11, no. 2, pp. 105–109.

    Google Scholar 

  12. Stryuk, R.I., Brytkova, Ya.V., Burlakova, B.N., et al., Gender features of risk factors of cardiovascular diseases in mid-age patients, Med. Sovet, 2013, no. 9, pp. 106–108.

    Google Scholar 

  13. Shal’nova, S.A., Epidemiology of arterial hypertension in Russia: a portrait of a patient, Arterial’naya Gipertenz., 2008, vol. 2, no. 2, pp. 57–58.

    Google Scholar 

  14. Aronow, W.S. and Ahn, C., Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease, Am. J. Cardiol., 1996, vol. 77, no. 10, pp. 864–866.

    Article  CAS  PubMed  Google Scholar 

  15. Aronow, W.S. and Ahn, C., Association of electrocardiographic left ventricular hypertrophy with the incidence of new congestive heart failure, J. Am. Geriatr. Soc., 1998, vol. 12, no. 10, pp. 1280–1281.

    Article  Google Scholar 

  16. Aronow, W.S. and Frishman, W.H., Management of hyperholesterinemia in older persons for the prevention of cardiovascular disease, Cardiol. Rev., 2010, vol. 18, no. 3, pp. 132–140.

    Article  PubMed  Google Scholar 

  17. Bahrami, H., Bluemke, D., Kronmal, R., et al., Novel metabolic risk factors for incident heart failure and their relationship with obesity the MESA (Multi-Ethnic Study of Atherosclerosis) study, J. Am. Coll. Cardiol., 2008, vol. 51, no. 18, pp. 1775–1783.

    Article  CAS  PubMed  Google Scholar 

  18. Barbieri, A., Bursi, F., Mantovani, F., et al., Left ventricular hypertrophy reclassification and death: application of the recommendation of the American Society of Echocardiography/European Association of echocardiography, Eur. Heart J. Cardiovasc. Imaging, 2012, vol. 13, no. 1, pp. 109–117.

    Article  PubMed  Google Scholar 

  19. Barsukov, A.V., Mirokhina, M.A., and Zobnina, M.P., Cardiac ultrasound parameters in euglycemic males with mild essential hypertension depending on one hour postload glycemia level, J. Hypertens., 2014, vol. 32, suppl., (in press).

  20. Barsukov, A., Sveklina, T., and Shoustov, S., Comparative analysis of essential hypertensive patients survival in dependence of concomitant conditions, J. Hypertens., 2011, vol. 29, suppl. A, p. 413.

    Article  Google Scholar 

  21. Barsukov, A., Zobnina, M., Shoustov, S., and Gordienko, A., Long-term outcome in essential hypertensive persons with different types of left ventricular hypertrophy and overt metabolic syndrome, J. Hypertens., 2013, vol. 31, suppl. A, p. e157.

    Google Scholar 

  22. Barsukov, A., Bagaeva, Z., Lokshina, T., et al., Echo cardiographic data in overweight essential hypertensive patients with different types of left ventricular hypertrophy, J. Hypertens., 2010, vol. 28, suppl., p. e568.

    Article  Google Scholar 

  23. Brandt, M.C., Mahfoud, F., Reda, S., et al., Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension, J. Am. Coll. Cardiol., 2012, vol. 59, no. 10, pp. 901–909.

    Article  PubMed  Google Scholar 

  24. Coca, A., Gabriel, R., Lopez-Sendon, J., et al., The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study, J. Hypertens., 1999, vol. 17, no. 10, pp. 1471–1480.

    Article  CAS  PubMed  Google Scholar 

  25. De Simone, G. and Palmieri, V., Left ventricular hypertrophy in hypertension as a predictor of coronary events: relation to geometry, Curr. Opin. Nephrol. Hypertens., 2002, vol. 11, no. 2, pp. 215–220.

    Article  PubMed  Google Scholar 

  26. De Simone, G., Devereux, R., Chinali, M., et al., Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study, Nutr. Metab. Cardiovasc. Dis., 2009, vol. 19, no. 2, pp. 98–104.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Devereux, R., Palmieri, V., Sharpe, N., et al., Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of left ventricular enlargement (PRESERVE) trial, Circulation, 2001, vol. 104, no. 11, pp. 1248–1254.

    Article  CAS  PubMed  Google Scholar 

  28. Djoussé, L. and Gaziano, J., Egg consumption in relation to cardiovascular disease and mortality: the physicians health study, Am. J. Clin. Nutr., 2008, vol. 87, no. 4, pp. 964–969.

    PubMed Central  PubMed  Google Scholar 

  29. Du, X., Ninomiya, T., Abadir, E., et al., Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study, Eur. Heart J., 2009, vol. 30, no. 9, pp. 1128–1135.

    Article  PubMed  Google Scholar 

  30. Ford, E.S., Giles, W.H., and Dietz, W.H., Prevalence of the metabolic syndrome among USadults: findings from the third National Health and Nutrition Examination Survey, J. Am. Med. Assoc., 2002, vol. 287, pp. 356–359.

    Article  Google Scholar 

  31. Ghali, J., Kadakia, S., Cooper, R., et al., Impact of left ventricular hypertrophy patterns on ventricular arrhythmias in the absence of coronary artery disease, J. Am. Coll. Cardiol., 1991, vol. 17, no. 6, pp. 1277–1282.

    Article  CAS  PubMed  Google Scholar 

  32. Glukhovskoy, D., Barsukov, A., Babanova, A., et al., Some peculiarities of 24-h electrocardiogram in essential hypertensive persons with normal and enlarged left atrial volume index, J. Hypertens., 2013, vol. 31, suppl. A, p. e315.

    Google Scholar 

  33. Go, A., Mozaffarian, D., Roger, V., et al., Heart disease and stroke statistics–2013 update: a report from the American Heart Association, Circulation, 2013, vol. 127, no. 1, pp. e6–e2.

    Article  PubMed  Google Scholar 

  34. Gueyffier, F., Boissel, J., Pocock, S., et al., Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database, Circulation, 1999, vol. 100, no. 18, pp. e88–94.

    Article  Google Scholar 

  35. Haywood, L.J., Ford, C.E., Crow, R.S., et al., Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and lipid-Lowering Treatment to Prevent Heart Attack Trial), J. Am. Coll. Cardiol., 2009, vol. 54, no. 22, pp. 2023–2031.

    Article  CAS  PubMed  Google Scholar 

  36. Jackson, R., Lawes, C., Bennett, D., et al., Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk, Lancet, 2005, vol. 365, no. 9457, pp. 434–441.

    Article  CAS  PubMed  Google Scholar 

  37. Julien, J., Tranche, C., and Souchet, T., Left ventricular hypertrophy in hypertensive patients. Epidemiology and prognosis, Arch. Mal. Coeur. Vaiss., 2004, vol. 97, no. 3, pp. 221–227.

    CAS  PubMed  Google Scholar 

  38. Kannel, W.B., Risk stratification in hypertension: new insights from the Framingham Study, Am. J. Hypertens., 2000, vol. 13, no. 1, pp. 3–10.

    Article  Google Scholar 

  39. Kannel, W.B., Wolf, P.A., Benjamin, E.J., et al., Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates, Am. J. Cardiol., 1998, vol. 82, no. 8A, pp. 2N–9N.

  40. Kendall, D.M., Sobel, B.E., Coulson, A.M., et al., The insulin resistance syndrome and coronary artery disease, Coron. Artery Dis., 2003, vol. 14, no. 4, pp. 335–348.

    Article  PubMed  Google Scholar 

  41. Koren, M.J., Devereux, R.B., Casale, P.N., et al., Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension, Ann. Intern. Med., 1991, vol. 114, no. 5, pp. 345–352.

    Article  CAS  PubMed  Google Scholar 

  42. Kotchen, T.A., Obesity-related hypertension: epidemiology, pathophysiology, and clinical management, Am. J. Hypertens., 2010, vol. 23, no. 11, pp. 1170–1178.

    Article  CAS  PubMed  Google Scholar 

  43. Krumholz, H., Larson, M., and Levy, D., Prognosis of left ventricular geometric patterns in the Framingham heart study, J. Am. Coll. Cardiol., 1995, vol. 25, no. 4, pp. 885–887.

    Article  Google Scholar 

  44. Kunisek, J., Zaputovic, L., Butorac, M.Z., et al., The prevalence of supraventricular arrhythmias with regard to the type and degree of left ventricular hypertrophy in patients with hypertensive heart disease, Wien. Klin. Wochenschr., 2008, vol. 120, nos. 5–6, pp. 171–177.

    Article  PubMed  Google Scholar 

  45. Kunisek, J., Zaputović, L., Mavrić, Z., et al., Influence of the type and degree of left ventricular hypertrophy on the prevalence of ventricular arrhythmias in patients with hypertensive heart disease, Med. Klin., 2008, vol. 103, no. 10, pp. 705–711.

    Article  Google Scholar 

  46. Larstorp, A.C., Okin, P.M., Devereux, R.B., et al., Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study, Am. J. Hypertens., 2012, vol. 25, no. 10, pp. 1101–1109.

    Article  PubMed  Google Scholar 

  47. Levy, D., Garrison, R., Savage, D., et al., Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study, N. Engl. J. Med., 1990, vol. 322, no. 22, pp. 1561–1566.

    Article  CAS  PubMed  Google Scholar 

  48. Lombardi, F. and Terranova, P., Hypertension and concurrent arrhythmias, Curr. Pharm. Des., 2003, vol. 9, no. 21, pp. 1703–1713.

    Article  CAS  PubMed  Google Scholar 

  49. Mancia, G., Metabolic syndrome in the Pressioni Arteriose Monitorate E Lolo Associazioni (PAMELA) study: daily life blood pressure, cardiac damage and prognosis, Hypertension, 2007, vol. 49, no. 1, pp. 40–47.

    Article  CAS  PubMed  Google Scholar 

  50. Mancia, G., De Backer, G., Dominiczak, A., et al., 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J. Hypertens., 2007, vol. 25, no. 6, pp. 1105–1187.

    Article  CAS  PubMed  Google Scholar 

  51. Mattsson, N., Metabolic syndrome in young adults—prevalence, childhood predictors and association with subclinical atherosclerosis, PhD Thesis, Turku, Finland: Univ. of Turku, 2012.

    Google Scholar 

  52. Nunez, B.D., Lavie, C.J., Messerli, F.H., et al., Comparison of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy, Am. J. Cardiol., 1994, vol. 74, no. 6, pp. 585–589.

    Article  CAS  PubMed  Google Scholar 

  53. Paoletti, E., Bellino, D., Gallina, A., et al., Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease?, Nephrol., Dial., Transplant., 2010, vol. 26, no. 2, pp. 670–677.

    Article  Google Scholar 

  54. Pedretti, R., Catalano, O., Ballardini, L., et al., Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocar diographic RRinterval but not QT dispersion, Int. J. Cardiol., 1999, vol. 68, no. 1, pp. 83–93.

    Article  CAS  PubMed  Google Scholar 

  55. Rosamond, W., Flegal, K., Furie, K., et al., Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 2008, vol. 117, no. 4, pp. e25–146.

    Article  Google Scholar 

  56. Schannwell, C.M., Steiner, S., Hennersdorf, M.G., et al., Cardiovascular and organ impairment due to hypertension, Internist, 2005, vol. 46, no. 5, pp. 496–508.

    Article  CAS  PubMed  Google Scholar 

  57. Schnabel, R.B., Sullivan, L.M., Levy, D., et al., Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study, Lancet, 2009, vol. 373, no. 9665, pp. 739–745.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Takase, H., Dohi, Y., Toriyama, T., et al., Brachialankle pulse wave velocity predicts increase in blood pressure and onset of hypertension, Am. J. Hypertens., 2011, vol. 24, no. 6, pp. 667–673.

    Article  PubMed  Google Scholar 

  59. Thaman, R.S., Gimeno, J.R., Reith, S., et al., Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy, J. Am. Coll. Cardiol., 2004, vol. 44, no. 2, pp. 398–405.

    Article  PubMed  Google Scholar 

  60. Thomas, F., Bean, K., Guize, L., et al., Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women, Eur. Heart J., 2002, vol. 23, no. 7, pp. 528–535.

    Article  CAS  PubMed  Google Scholar 

  61. Tian, J.P., Wang, T., Wang, H., et al., The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients, Renal Failure, 2008, vol. 30, no. 4, pp. 391–400.

    Article  PubMed  Google Scholar 

  62. Tsioufis, C., Vezali, E., Tsiachris, D., et al., Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study, J. Hypertens., 2009, vol. 27, no. 4, pp. 744–752.

    Article  CAS  PubMed  Google Scholar 

  63. Vakili, B., Okin, P., and Devereux, R., Prognostic implications of left ventricular hypertrophy, Am. Heart J., 2001, vol. 141, no. 3, pp. 334–341.

    Article  CAS  PubMed  Google Scholar 

  64. Vasan, R.S., Benjamin, E.J., and Levy, D., Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective, J. Am. Coll. Cardiol., 1995, vol. 26, no. 7, pp. 1565–1574.

    Article  CAS  PubMed  Google Scholar 

  65. Vasiliev, V.N., Dydyshko, V.T., Romanova, E.P., and Barsukov, A.V., Cardiac ultrasound parameters in young males with prehypertension and the first stage hypertension depending on cardiovascular risk level, J. Hypertens., 2014, vol. 32, suppl. (in press).

  66. Verdecchia, P., Angeli, F., Achilli, P., et al., Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?, Curr. Opin. Cardiol., 2007, vol. 22, no. 4, pp. 329–334.

    Article  PubMed  Google Scholar 

  67. Verdecchia, P., Schilacci, G., Borgioni, C., et al., Prognostic significance of serial changes in left ventricular mass in essential hypertension, Circulation, 1998, vol. 97, no. 1, pp. 48–54.

    Article  CAS  PubMed  Google Scholar 

  68. Whaley-Connell, A. and Sowers, J.R., Indices of obesity and cardiometabolic risk, Hypertension, 2011, vol. 58, no. 6, pp. 991–993.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  69. Wild, P., Sinning, C., Roth, A., et al., Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg heart study, Circ. Cardiovasc. Imaging, 2010, vol. 3, no. 5, pp. 604–613.

    Article  PubMed  Google Scholar 

  70. Wong, N.D., Wilson, P.W., and Kannel, W.B., Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham study, Ann. Intern. Med., 1991, vol. 115, no. 9, pp. 687–693.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. V. Barsukov.

Additional information

Original Russian Text © A.V. Barsukov, D.V. Glukhovskoy, M.P. Zobnina, M.A. Mirokhina, V.T. Dydyshko, V.N. Vasiliev, V.P. Kitzishin, V.V. Tishko, 2014, published in Uspekhi Gerontologii, 2014, Vol. 27, No. 4, pp. 763–770.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barsukov, A.V., Glukhovskoy, D.V., Zobnina, M.P. et al. Left ventricular hypertrophy as a marker of adverse cardiovascular risk in persons of different age groups. Adv Gerontol 5, 99–106 (2015). https://doi.org/10.1134/S2079057015020022

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079057015020022

Keywords

Navigation